APOLLOHOSP8,894.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.28L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity12.2816.7119.4719.47
Return on Assets5.587.299.029.02
Return on Capital Employed14.0914.0818.4118.41
Return on Invested Capital12.3413.9415.6816.94
Margins
EBITDA Margin12.5413.8714.9415.17
Operating Margin8.9410.3911.4711.47
Incremental Operating Margin20.5018.31
Pretax Margin7.159.2010.3710.72
Net Income Margin4.916.917.948.22
Net Income to Common Margin4.716.637.707.91
FCF Margin4.111.943.543.54
Additional
Effective Tax Rate32.7026.6225.1624.89
Dvd Payout Ratio23.6318.5014.62
Sustainable Growth Rate9.3813.6216.6219.47
Incremental Operating Margin %20.5018.3118.30
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.